Yvonne Freund‐Levi

ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study

Yvonne Freund‐Levi, Maria Eriksdotter, Tommy Cederholm et al. · Archives of Neurology · 2006 · 746 citations

Medicine, Nutritional Sciences, Pharmacology +17

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

Pieter Jelle Visser, Frans R.J. Verhey, Dirk L. Knol et al. · The Lancet Neurology · 2009 · 621 citations

Medicine, Neurology, Neuroscience +16

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and <i>APOE</i> genotype

Lisa Vermunt, Sietske A.M. Sikkes, Ardo van den Hout et al. · Alzheimer s & Dementia · 2019 · 573 citations · Full text

Medicine, Neurology, Neuroscience +17

Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage

Stephanie J. B. Vos, Frans R.J. Verhey, Lutz Frölich et al. · Brain · 2015 · 393 citations · Full text

Medicine, Geriatric Medicine, Neurology +17

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

Willemijn J. Jansen, Olin Janssen, Betty M. Tijms et al. · JAMA Neurology · 2022 · 288 citations · Full text

Medicine, Neurology, Neuroscience +17